201 related articles for article (PubMed ID: 32735027)
1. Preliminary characterization of the properties of cold-stored apheresis platelets suspended in PAS-III with and without an 8-hour room temperature hold.
Wagner SJ; Getz TM; Thompson-Montgomery D; Turgeon A
Transfusion; 2020 Nov; 60(11):2489-2493. PubMed ID: 32735027
[TBL] [Abstract][Full Text] [Related]
2. An in vitro pilot study of apheresis platelets collected on Trima Accel system and stored in T-PAS+ solution at refrigeration temperature (1-6°C).
Reddoch-Cardenas KM; Sharma U; Salgado CL; Montgomery RK; Cantu C; Cingoz N; Bryant R; Darlington DN; Pidcoke HF; Kamucheka RM; Cap AP
Transfusion; 2019 May; 59(5):1789-1798. PubMed ID: 30725491
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of in vitro storage properties of apheresis platelets suspended in a bicarbonate-containing additive solution with low levels of plasma and stored with a 24-hour interruption of agitation.
Skripchenko A; Turgeon A; Thompson-Montgomery D; Awatefe H; Wagner SJ
Vox Sang; 2014 May; 106(4):337-43. PubMed ID: 24330192
[TBL] [Abstract][Full Text] [Related]
4. In vivo viability of extended 4°C-stored autologous apheresis platelets.
Stolla M; Fitzpatrick L; Gettinger I; Bailey SL; Pellham E; Christoffel T; Slichter SJ
Transfusion; 2018 Oct; 58(10):2407-2413. PubMed ID: 30203458
[TBL] [Abstract][Full Text] [Related]
5. Quality assessment of platelets stored in a modified platelet additive solution with trehalose at low temperature (10 °C) and in vivo effects on rabbit model of thrombocytopenia.
Wang X; Fan Y; Shi R; Li J; Zhao S
Platelets; 2015; 26(1):72-9. PubMed ID: 24499059
[TBL] [Abstract][Full Text] [Related]
6. Refrigeration of apheresis platelets in platelet additive solution (PAS-E) supports in vitro platelet quality to maximize the shelf-life.
Johnson L; Vekariya S; Wood B; Tan S; Roan C; Marks DC
Transfusion; 2021 Jul; 61 Suppl 1():S58-S67. PubMed ID: 34269458
[TBL] [Abstract][Full Text] [Related]
7. Cold storage of platelets in platelet additive solution: an in vitro comparison of two Food and Drug Administration-approved collection and storage systems.
Reddoch-Cardenas KM; Montgomery RK; Lafleur CB; Peltier GC; Bynum JA; Cap AP
Transfusion; 2018 Jul; 58(7):1682-1688. PubMed ID: 29603238
[TBL] [Abstract][Full Text] [Related]
8. In vitro quality and platelet function of cold and delayed cold storage of apheresis platelet concentrates in platelet additive solution for 21 days.
Braathen H; Sivertsen J; Lunde THF; Kristoffersen EK; Assmus J; Hervig TA; Strandenes G; Apelseth TO
Transfusion; 2019 Aug; 59(8):2652-2661. PubMed ID: 31150571
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the automated collection and extended storage of apheresis platelets in additive solution.
Johnson L; Winter KM; Hartkopf-Theis T; Reid S; Kwok M; Marks DC
Transfusion; 2012 Mar; 52(3):503-9. PubMed ID: 21880041
[TBL] [Abstract][Full Text] [Related]
10. P38 mitogen activated protein kinase inhibitor improves platelet in vitro parameters and in vivo survival in a SCID mouse model of transfusion for platelets stored at cold or temperature cycled conditions for 14 days.
Skripchenko A; Gelderman MP; Vostal JG
PLoS One; 2021; 16(5):e0250120. PubMed ID: 33974660
[TBL] [Abstract][Full Text] [Related]
11. Impact of different hold time before addition of platelet additive solution on the in vitro quality of apheresis platelets.
Ringwald J; Haager B; Krex D; Zimmermann R; Strasser E; Antoon M; De Schrijver E; Eckstein R
Transfusion; 2006 Jun; 46(6):942-8. PubMed ID: 16734810
[TBL] [Abstract][Full Text] [Related]
12. Addition of sialidase or p38 MAPK inhibitors does not ameliorate decrements in platelet in vitro storage properties caused by 4 °C storage.
Skripchenko A; Thompson-Montgomery D; Awatefe H; Turgeon A; Wagner SJ
Vox Sang; 2014 Nov; 107(4):360-7. PubMed ID: 24976248
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets.
Charania R; Smith J; Vesely SK; Dale GL; Holter J
Transfusion; 2011 Dec; 51(12):2690-4. PubMed ID: 21645004
[TBL] [Abstract][Full Text] [Related]
14. A rest period does not affect in vitro storage properties in apheresis platelets collected from the buffy coat layer.
Wagner SJ; Seetharaman S; Kurtz J
Transfusion; 2012 Nov; 52(11):2427-31. PubMed ID: 22452313
[TBL] [Abstract][Full Text] [Related]
15. Effect of cold storage on shear-induced platelet aggregation and clot strength.
Nair PM; Pidcoke HF; Cap AP; Ramasubramanian AK
J Trauma Acute Care Surg; 2014 Sep; 77(3 Suppl 2):S88-93. PubMed ID: 25159368
[TBL] [Abstract][Full Text] [Related]
16. Storage of platelets at 4°C in platelet additive solutions prevents aggregate formation and preserves platelet functional responses.
Getz TM; Montgomery RK; Bynum JA; Aden JK; Pidcoke HF; Cap AP
Transfusion; 2016 Jun; 56(6):1320-8. PubMed ID: 26853912
[TBL] [Abstract][Full Text] [Related]
17. The role of bicarbonate in platelet additive solution for apheresis platelet concentrates stored with low residual plasma.
Radwanski K; Min K
Transfusion; 2013 Mar; 53(3):591-9. PubMed ID: 22725609
[TBL] [Abstract][Full Text] [Related]
18. Automated cold temperature cycling improves in vitro platelet properties and in vivo recovery in a mouse model compared to continuous cold storage.
Skripchenko A; Gelderman MP; Awatefe H; Turgeon A; Thompson-Montgomery D; Cheng C; Vostal JG; Wagner SJ
Transfusion; 2016 Jan; 56(1):24-32. PubMed ID: 26331697
[TBL] [Abstract][Full Text] [Related]
19. Refrigeration and cryopreservation of platelets differentially affect platelet metabolism and function: a comparison with conventional platelet storage conditions.
Johnson L; Tan S; Wood B; Davis A; Marks DC
Transfusion; 2016 Jul; 56(7):1807-18. PubMed ID: 27158813
[TBL] [Abstract][Full Text] [Related]
20. Metabolic phenotypes of standard and cold-stored platelets.
D'Alessandro A; Thomas KA; Stefanoni D; Gamboni F; Shea SM; Reisz JA; Spinella PC
Transfusion; 2020 Jun; 60 Suppl 3(Suppl 3):S96-S106. PubMed ID: 31880330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
